Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
暂无分享,去创建一个
Anne-Claude Gingras | Trevor J. Pugh | Trevor J Pugh | Payman Samavarchi-Tehrani | A. Gingras | T. Pugh | R. Quevedo | D. Schramek | B. Rathod | P. Samavarchi-Tehrani | Daniel Schramek | Rene Quevedo | Bhavisha Rathod | Sampath K. Loganathan | Krista Schleicher | Ahmad Malik | Ellen Langille | Katie Teng | Robin H. Oh | Ricky Tsai | Ellen Langille | S. Loganathan | A. Malik | R. Tsai | Katie Teng | Krista Schleicher | Robin H Oh | R. H. Oh | Payman Samavarchi-Tehrani
[1] S. Henikoff,et al. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites , 2016, bioRxiv.
[2] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[3] M. Bailly,et al. Ajuba is required for Rac activation and maintenance of E-cadherin adhesion , 2011, The Journal of cell biology.
[4] Amber L. Couzens,et al. The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.
[5] A. Gingras,et al. Parallel Exploration of Interaction Space by BioID and Affinity Purification Coupled to Mass Spectrometry. , 2017, Methods in molecular biology.
[6] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[7] T. Akiyama,et al. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3β-mediated phosphorylation of β-catenin , 2008, Oncogene.
[8] M. Zenke,et al. Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors , 2010, PloS one.
[9] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[10] A. Kulkarni,et al. Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation , 2012, Oncogene.
[11] Elaine Fuchs,et al. Canonical notch signaling functions as a commitment switch in the epidermal lineage. , 2006, Genes & development.
[12] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[13] K. Billiar,et al. TRIP6 inhibits Hippo signaling in response to tension at adherens junctions , 2018, EMBO reports.
[14] K. Guan,et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. , 2011, Genes & development.
[15] E. Shoubridge,et al. A proximity biotinylation map of a human cell , 2019, bioRxiv.
[16] A. Rustgi,et al. Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. , 2016, Cancer cell.
[17] N. Socci,et al. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. , 2014, Cancer discovery.
[18] G. Longmore,et al. Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway , 2010, Current Biology.
[19] I. Tomlinson,et al. The mini-driver model of polygenic cancer evolution , 2015, Nature Reviews Cancer.
[20] Rohit Reja,et al. The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function , 2019, Nature.
[21] Anshul Kundaje,et al. The ENCODE Blacklist: Identification of Problematic Regions of the Genome , 2019, Scientific Reports.
[22] M. Duffy,et al. The ADAMs family of proteases as targets for the treatment of cancer , 2016, Cancer biology & therapy.
[23] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[24] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[25] S. Egan,et al. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. , 2011, Cancer research.
[26] Joshua M. Stuart,et al. Resource Genomic , Pathway Networ k , and Immunologic Features Distinguishing Squamous Carcinomas Graphical , 2018 .
[27] C. Blobel,et al. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling , 2011, Development.
[28] Yi Zhou,et al. A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. , 2015, Developmental cell.
[29] E. Shoubridge,et al. A proximity-dependent biotinylation map of a human cell , 2021, Nature.
[30] C. McGlade,et al. Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.
[31] H. Saya,et al. Aurora-A and an Interacting Activator, the LIM Protein Ajuba, Are Required for Mitotic Commitment in Human Cells , 2003, Cell.
[32] Tony Pawson,et al. Protein Interaction Network of the Mammalian Hippo Pathway Reveals Mechanisms of Kinase-Phosphatase Interactions , 2013, Science Signaling.
[33] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[34] Ruud H. Brakenhoff,et al. The molecular landscape of head and neck cancer , 2018, Nature Reviews Cancer.
[35] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[36] S. Molyneux,et al. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. , 2012, Immunity.
[37] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[38] E. Wagner,et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. , 2012, The Journal of clinical investigation.
[39] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[40] Steven J. M. Jones,et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.
[41] Elaine Fuchs,et al. Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas , 2014, Science.
[42] E. Lander,et al. Lessons from the Cancer Genome , 2013, Cell.
[43] E. Fuchs,et al. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos , 2010, Nature Medicine.
[44] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[45] F. Radtke,et al. Notch as a tumour suppressor , 2017, Nature Reviews Cancer.
[46] E. Fuchs,et al. RNAi-mediated gene function analysis in skin. , 2013, Methods in molecular biology.
[47] H. Stunnenberg,et al. Dynamic binding of RBPJ is determined by Notch signaling status. , 2013, Genes & development.
[48] A. Emili,et al. DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2 , 2016, Genes & development.
[49] C. Sander,et al. Genome Sequencing Identifies a Basis for Everolimus Sensitivity , 2012, Science.
[50] Junjie Chen,et al. Angiomotin-like Proteins Associate with and Negatively Regulate YAP1* , 2010, The Journal of Biological Chemistry.